Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor.

  • Stanley, Nathaniel H., 1983-
  • Pardo, Leonardo
  • De Fabritiis, Gianni
The binding process through the membrane bilayer of lipid-like ligands to a protein target is an important but poorly explored recognition process at the atomic level. In this work we succeeded in resolving the binding of the lipid inhibitor ML056 to the sphingosine-1-phosphate receptor 1 (S1P1R) using unbiased molecular dynamics simulations with an aggregate sampling of over 800 μs. The binding pathway is a multi-stage process consisting of the ligand diffusing in the bilayer leaflet to contact a "membrane vestibule" at the top of TM 7, subsequently moving from this lipid-facing vestibule to the orthosteric binding cavity through a channel formed by TMs 1 and 7 and the N-terminal of the receptor. Unfolding of the N-terminal alpha-helix increases the volume of the channel upon ligand entry, helping to reach the crystallographic pose that also corresponds to the predicted favorable pose. The relaxation timescales of the binding process show that the binding of the ligand to the "membrane vestibule" is the rate-limiting step in the multi microseconds timescale. We comment on the significance and parallels of the binding process in the context of other binding studies., The authors would like to thank the volunteers of GPUGRID.net for donating compute time to this project. LP (SAF2013-48271-C2-2-R) and GDF (BIO2014-53095-P) acknowledge support by the Spanish Ministry of Science and Innovation and FEDER.
Repisalud
Publication Artículo científico (JournalArticle)

The structural assembly switch of cell division protein FtsZ probed with fluorescent allosteric inhibitors.

  • Artola, Marta
  • Ruíz-Avila, Laura B
  • Ramírez-Aportela, Erney
  • Martínez, R Fernando
  • Araujo-Bazán, Lidia
  • Vázquez-Villa, Henar
  • Martín-Fontecha, Mar
  • Oliva, María A
  • Martin-Galiano, Antonio Javier
  • Chacón, Pablo
  • López-Rodríguez, María L
  • Andreu, José M
  • Huecas, Sonia
FtsZ is a widely conserved tubulin-like GTPase that directs bacterial cell division and a new target for antibiotic discovery. This protein assembly machine cooperatively polymerizes forming single-stranded filaments, by means of self-switching between inactive and actively associating monomer conformations. The structural switch mechanism was proposed to involve a movement of the C-terminal and N-terminal FtsZ domains, opening a cleft between them, allosterically coupled to the formation of a tight association interface between consecutive subunits along the filament. The effective antibacterial benzamide PC190723 binds into the open interdomain cleft and stabilizes FtsZ filaments, thus impairing correct formation of the FtsZ ring for cell division. We have designed fluorescent analogs of PC190723 to probe the FtsZ structural assembly switch. Among them, nitrobenzoxadiazole probes specifically bind to assembled FtsZ rather than to monomers. Probes with several spacer lengths between the fluorophore and benzamide moieties suggest a binding site extension along the interdomain cleft. These probes label FtsZ rings of live and , without apparently modifying normal cell morphology and growth, but at high concentrations they induce impaired bacterial division phenotypes typical of benzamide antibacterials. During the FtsZ assembly-disassembly process, the fluorescence anisotropy of the probes changes upon binding and dissociating from FtsZ, thus reporting open and closed FtsZ interdomain clefts. Our results demonstrate the structural mechanism of the FtsZ assembly switch, and suggest that the probes bind into the open clefts in cellular FtsZ polymers preferably to unassembled FtsZ in the bacterial cytosol.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections

  • Aguinagalde, Leire
  • Díez-Martínez, Roberto
  • Royo, Inmaculada
  • Gil, Carmen
  • Lasa, Íñigo
  • García González, Pedro
  • García, Ernesto
  • Sánchez-Puelles, José María
Aguinagalde, Leire et al., [Background] Auranofin is an FDA-approved, gold-containing compound in clinical use for the oral treatment of rheumatoid arthritis and has been recently granted by the regulatory authorities due to its antiprotozoal properties., [Methods] A reprofiling strategy was performed with a Streptococcus pneumoniae phenotypic screen and a proprietary library of compounds, consisting of both FDA-approved and unapproved bioactive compounds. Two different multiresistant S. pneumoniae strains were employed in a sepsis mouse model of infection. In addition, an MRSA strain was tested using both the thigh model and a mesh-associated biofilm infection in mice., [Results] The repurposing approach showed the high potency of auranofin against multiresistant clinical isolates of S. pneumoniae and Staphylococcus aureus in vitro and in vivo. Efficacy in the S. pneumoniae sepsis model was obtained using auranofin by the oral route in the dose ranges used for the treatment of rheumatoid arthritis. Thioglucose replacement by alkyl chains showed that this moiety was not essential for the antibacterial activity and led to the discovery of a new gold derivative (MH05) with remarkable activity in vitro and in vivo., [Conclusions] Auranofin and the new gold derivative MH05 showed encouraging in vivo activity against multiresistant clinical isolates of S. pneumoniae and S. aureus. The clinical management of auranofin, alone or in combination with other antibiotics, deserves further exploration before use in patients presenting therapeutic failure caused by infections with multiresistant Gram-positive pathogens. Decades of clinical use mean that this compound is safe to use and may accelerate its evaluation in humans., This work was supported by grants SAF2009-10824, SAF2012-39444-C01/02, SAF2013-48271, BIO2011-30503, AES/PI12/01628 (Ministerio de Economía y Competitividad; MINECO), CM S2011/BMED-2353 (Comunidad de Madrid) and FEDER Funds. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) is an initiative of the Instituto de Salud Carlos III (ISCIII). L. A. was supported by an FPI fellowship from MINECO., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs

  • Mecha, Miriam
  • Feliú, Ana
  • Machín-Díaz, Isabel
  • Cordero, César
  • Carrillo-Salinas, F. J.
  • Mestre, Leyre
  • Hernández-Torres, Gloria
  • López-Rodríguez, María L.
  • Castro Soubriet, Fernando de
  • Clemente, Diego
  • Guaza, Carmen
The innate immune response is mediated by primary immune modulators such as cytokines and chemokines that together with immune cells and resident glia orchestrate CNS immunity and inflammation. Growing evidence supports that the endocannabinoid 2‐arachidonoylglycerol (2‐AG) exerts protective actions in CNS injury models. Here, we used the acute phase of Theiler's virus induced demyelination disease (TMEV‐IDD) as a model of acute neuroinflammation to investigate whether 2‐AG modifies the brain innate immune responses to TMEV and CNS leukocyte trafficking. 2‐AG or the inhibition of its hydrolysis diminished the reactivity and number of microglia at the TMEV injection site reducing their morphological complexity and modulating them towards an anti‐inflammatory state via CB2 receptors. Indeed, 2‐AG dampened the infiltration of immune cells into the CNS and inhibited their egress from the spleen, resulting in long‐term beneficial effects at the chronic phase of the disease. Intriguingly, it is not a generalized action over leukocytes since 2‐AG increased the presence and suppressive potency of myeloid derived suppressor cells (MDSCs) in the brain resulting in higher apoptotic CD4+ T cells at the injection site. Together, these data suggest a robust modulatory effect in the peripheral and central immunity by 2‐AG and highlight the interest of modulating endogenous cannabinoids to regulate CNS inflammatory conditions., This work was supported by grants to CG, DC and MLR from Ministry of the Economy and Competitiveness (CG: MINECO SAF2013–42784‐R, SAF2016 76449‐R; MLR: SAF2013–48271, DC: PI15/00963), the Comunidad de Madrid (CG: S2010/BMD‐2308 and MLR: S2010/BMD‐2353), the Red Española de Esclerosis Múltiple (CG: REEM: RD12/0032/0008; RD16/0015/0021; FC: RD12/0032/12, DC: RD16/0015/0019) sponsored by the Fondo de Investigación Sanitaria (FIS), partially financed by F.E.D.E.R.; European Union “Una manera de hacer Europa” and ARSEP Foundation to DC. Diego Clemente's group was sponsored by ADEM‐TO, Aciturri Aeronáutica S.L. and Vesuvius Ibérica LA. M.M. is a senior postdoctoral supported by the Comunidad de Madrid (S2010/BMD‐2308) and hired by MINECO; DC and IM‐D are hired by SESCAM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination

  • Feliú, Ana
  • Bonilla del Río, Itziar
  • Carrillo-Salinas, F. J.
  • Hernández-Torres, Gloria
  • Puente, Nagore
  • Ortega-Gutiérrez, S.
  • López-Rodríguez, María L.
  • Grandes, Pedro
  • Mecha, Miriam
  • Guaza, Carmen
The failure to undergo remyelination is a critical impediment to recovery in multiple sclerosis. Chondroitin sulfate proteoglycans (CSPGs) accumulate at demyelinating lesions creating a nonpermissive environment that impairs axon regeneration and remyelination. Here, we reveal a new role for 2-arachidonoylglycerol (2-AG), the major CNS endocannabinoid, in the modulation of CSPGs deposition in a progressive model of multiple sclerosis, the Theiler's murine encephalomyelitis virus-induced demyelinating disease. Treatment with a potent reversible inhibitor of the enzyme monoacylglycerol lipase, which accounts for 85% of the 2-AG degradation in the mouse CNS, modulates neuroinflammation and reduces CSPGs accumulation and astrogliosis around demyelinated lesions in the spinal cord of Theiler's murine encephalomyelitis virus-infected mice. Inhibition of 2-AG hydrolysis augments the number of mature oligodendrocytes and increases MBP, leading to remyelination and functional recovery of mice. Our findings establish a mechanism for 2-AG promotion of remyelination with implications in axonal repair in CNS demyelinating pathologies., This work was supported by Ministry of the Economy and Competition (MINECO) Grants SAF2013-42784-R and SAF2016-76449-R, Comunidad de Madrid Grant S2011/BMD-2308, and Red Española de Esclerosis Múltiple Grants RD12/0032/0008 and RD16/0015/0021 (sponsored by the Fondo de Investigación Sanitaria) to C.G., Basque Government Grant IT764-13, MINECO/FEDER Grant SAF2015-65034-R, and University of the Basque Country Grant UPV/EHU UFI11/41 to P.G., and MINECO Grant SAF2013-48271-C2-1-R to M.L.-R. None of the funding bodies played any role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. A.F. is a predoctoral fellow supported by MINECO Grant BES-2014-068459. We thank Laura Ramos for excellent technical support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Endocannabinoids drive the acquisition of an alternative phenotype in microglia

  • Mecha, Miriam
  • Feliú, Ana
  • Carrillo-Salinas, F. J.
  • Rueda-Zubiaurre, A.
  • Ortega-Gutiérrez, S.
  • García de Sola, R.
  • Guaza, Carmen
The ability of microglia to acquire diverse states of activation, or phenotypes, reflects different features that are determinant for their contribution to homeostasis in the adult CNS, and their activity in neuroinflammation, repair or immunomodulation. Despite the widely reported immunomodulatory effects of cannabinoids in both the peripheral immune system and the CNS, less is known about how the endocannabinoid signaling system (eCBSS) influence the microglial phenotype. The general aim of the present study was to investigate the role of endocannabinoids in microglia polarization by using microglia cell cultures. We show that alternative microglia (M2a) and acquired deactivated microglia (M2c) exhibit changes in the eCB machinery that favor the selective synthesis of 2-AG and AEA, respectively. Once released, these eCBs might be able to act through CB1 and/or CB2 receptors in order to influence the acquisition of an M2 phenotype. We present three lines of evidence that the eCBSS is critical for the acquisition of the M2 phenotype: (i) M2 polarization occurs on exposure to the two main endocannabinoids 2-AG and AEA in microglia cultures; (ii) cannabinoid receptor antagonists block M2 polarization; and (iii) M2 polarization is dampened in microglia from CB2 receptor knockout mice. Taken together, these results indicate the interest of eCBSS for the regulation of microglial activation in normal and pathological conditions., This work was supported by Grants from the Ministry of the Economy and Competition (MINECO SAF2013-42784-R and SAF2013-48271, the Comunidad de Madrid (S2010/BMD-2308 and S2010/BMD-2353) and the Red Española de Esclerosis Múltiple (REEM) RD12/0032/0008 (CG) sponsored by the Fondo de Investigación Sanitaria (FIS). A.R.Z. is a predoctoral fellow from UCM. M.M. is a senior postdoctoral supported by the Comunidad de Madrid (S2010/BMD-2308).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways

  • Gómez, Óscar
  • Sanchez-Rodriguez, María A.
  • Ortega-Gutiérrez, S.
  • Vazquez-Villa, Henar
  • Guaza, Carmen
  • Molina-Holgado, F.
  • Molina-Holgado, E.
A basal tone of the endocannabinoid 2-arachidonoylglycerol (2-AG) enhances late oligodendrocyte progenitor cell (OPC) differentiation. Here, we investigated whether endogenous 2-AG may also promote OPC proliferation in earlier stages. We found that the blockade of 2-AG synthesizing enzymes, sn-1-diacylglycerol lipases α and β (DAGLs), with RHC-80267 or the antagonism of either CB1 or CB2 cannabinoid receptors with AM281 and AM630, respectively, impaired early OPC proliferation stimulated by platelet-derived growth factor (PDGF-AA) and basic fibroblast growth factor (bFGF). On the contrary, increasing the levels of endogenous 2-AG by blocking the degradative enzyme monoacylglycerol lipase (MAGL) with JZL-184, significantly increased OPC proliferation as did agonists of cannabinoid receptor CB1 (ACEA), CB2 (JWH133) or both (HU-210). To elucidate signaling pathways underlying OPC proliferation, we studied the involvement of phosphatidylinositol 3-kinase (PI3K)/Akt and its downstream target mammalian target of rapamycin (mTOR). We show that phosphorylation of Akt and mTOR is required for OPC proliferation stimulated by growth factors (PDGF-AA and bFGF) or by CB1/CB2 agonists (ACEA/JWH133), since it was strongly decreased after LY294002 or rapamycin treatment. In line with this, blockade of CB1 (AM281), CB2 (AM630) or DAGLs (RHC-80267), decreased phosphorylation of Akt, mTOR and 4E-BP1, diminished cyclin E-cdk2 complex association and increased p27kip1 levels. Our data suggest that proliferation of early OPCs stimulated by PDGF-AA and bFGF depends on the tonic activation of cannabinoid receptors by endogenous 2-AG and provide further evidence on the role of endocannabinoids in oligodendrocyte development, being important for the maintenance and self-renewal of the OPCs. The results highlight the therapeutic potential of the endocannabinoid signaling in the emerging field of brain repair., This research was funded by the Ministry of Economy and Competitiveness of Spain to EM-H (MINECO, Instituto de Salud Carlos III; PI11/1729). SO-G was funded by MINECO (SAF2013-48271) and Comunidad de Madrid (S2010/BMD-2353). CG was supported by Red Española de Esclerosis Múltiple (REEM) RD12/0032/0008 sponsored by the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling

  • Marín-Ramos, Nagore I.
  • Piñar, Carmen
  • Vazquez-Villa, Henar
  • Martín-Fontecha, Mar
  • González, Ángel
  • Canales, Ángeles
  • Algar, S.
  • Mayo, Paloma P.
  • Jiménez-Barbero, Jesús
  • Gajate, Consuelo
  • Mollinedo, Faustino
  • Pardo, Leonardo
  • Ortega-Gutiérrez, S.
  • Viso, Alma
  • López-Rodríguez, María L.
Despite more than three decades of intense effort, no anti-Ras therapies have reached clinical application. Contributing to this failure has been an underestimation of Ras complexity and a dearth of structural information. In this regard, recent studies have revealed the highly dynamic character of the Ras surface and the existence of transient pockets suitable for small-molecule binding, opening up new possibilities for the development of Ras modulators. Herein, a novel Ras inhibitor (compound 12) is described that selectively impairs mutated Ras activity in a reversible manner without significantly affecting wild-type Ras, reduces the Ras–guanosine triphosphate (GTP) levels, inhibits the activation of the mitogen-activated protein kinase (MAPK) pathway, and exhibits remarkable cytotoxic activity in Ras-driven cellular models. The use of molecular dynamics simulations and NMR spectroscopy experiments has enabled the molecular bases responsible for the interactions between compound 12 and Ras protein to be explored. The new Ras inhibitor binds partially to the GTP-binding region and extends into the adjacent hydrophobic pocket delimited by switch II. Hence, Ras inhibitor 12 could represent a new compound for the development of more efficacious drugs to target Ras-driven cancers; a currently unmet clinical need., This work was supported by ExonHit Therapeutics and bygrants from the Spanish Ministerio de EconomíaayCompetitividad (MINECO, SAF2013-48271-R, SAF2014-59716-R, and SAF2016-78792-R) and Comunidad de Madrid (S2010/BMD-2353). We thank the Campus de Excelencia CEI Moncloa fora predoctora lfellowship to N.I.M.-R.,the UCM’sCAI Cytometryand Fluorescence Microscopy for their assistance, and the com-puter resources provided by the Barcelona Supercomputing Center-Centro Nacional de Supercomputación
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor.

  • Stanley, Nathaniel H., 1983-
  • Pardo, Leonardo
  • De Fabritiis, Gianni
The binding process through the membrane bilayer of lipid-like ligands to a protein target is an important but poorly explored recognition process at the atomic level. In this work we succeeded in resolving the binding of the lipid inhibitor ML056 to the sphingosine-1-phosphate receptor 1 (S1P1R) using unbiased molecular dynamics simulations with an aggregate sampling of over 800 μs. The binding pathway is a multi-stage process consisting of the ligand diffusing in the bilayer leaflet to contact a "membrane vestibule" at the top of TM 7, subsequently moving from this lipid-facing vestibule to the orthosteric binding cavity through a channel formed by TMs 1 and 7 and the N-terminal of the receptor. Unfolding of the N-terminal alpha-helix increases the volume of the channel upon ligand entry, helping to reach the crystallographic pose that also corresponds to the predicted favorable pose. The relaxation timescales of the binding process show that the binding of the ligand to the "membrane vestibule" is the rate-limiting step in the multi microseconds timescale. We comment on the significance and parallels of the binding process in the context of other binding studies., The authors would like to thank the volunteers of GPUGRID.net for donating compute time to this project. LP (SAF2013-48271-C2-2-R) and GDF (BIO2014-53095-P) acknowledge support by the Spanish Ministry of Science and Innovation and FEDER.
Docta Complutense
Publication Artículo científico (JournalArticle)

A positive allosteric modulator of the serotonin 5-HT2c receptor for obesity

  • García Cárceles, Javier
  • Decara, Juan M.
  • Vázquez Villa, María Del Henar
  • Rodríguez, Ramón
  • Codesido, Eva
  • Cruces, Jacobo
  • Brea, José
  • Loza, María Isabel
  • Alén Fariñas, Francisco
  • Botta, Joaquin
  • McCormick, Peter J.
  • Ballesteros, Juan A.
  • Benhamú Salama, Bellinda
  • Rodríguez De Fonseca, Fernando Antonio
  • López Rodríguez, María Luz
The 5-HT2CR agonist lorcaserin, clinically approved for the treatment of obesity, causes important side effects mainly related to subtype selectivity. In the search for 5-HT2CR allosteric modulators as safer antiobesity drugs, a chemical library from Vivia Biotech was screened using ExviTech platform. Structural modifications of identified hit VA240 in synthesized analogues 6–41 afforded compound 11 (N-[(1-benzyl-1H-indol-3-yl)methyl]pyridin-3-amine, VA012), which exhibited dose-dependent enhancement of serotonin efficacy, no significant off-target activities, and low binding competition with serotonin or other orthosteric ligands. PAM 11 was very active in feeding inhibition in rodents, an effect that was not related to the activation of 5-HT2AR. A combination of 11 with the SSRI sertraline increased the anorectic effect. Subchronic administration of 11 reduced food intake and body weight gain without causing CNS-related malaise. The behavior of compound 11 identified in this work supports the interest of a serotonin 5-HT2CR PAM as a promising therapeutic approach for obesity.
Docta Complutense
Publication Artículo científico (JournalArticle)

New inhibitors of angiogenesis with antitumor activity in vivo

  • Marín Ramos, Nagore I.
  • Alonso, Dulce
  • Ortega Gutiérrez, Silvia
  • Ortega Nogales, Francisco J.
  • Balabasquer, Moisés
  • Vázquez Villa, María Del Henar
  • Andradas, Clara
  • Blasco Benito, Sandra
  • Pérez Gómez, Eduardo
  • Canales Mayordomo, María Ángeles
  • Jiménez Barbero, Jesus
  • Marquina, Ana
  • Moscoso del Prado, Jaime
  • Sánchez García, María Cristina
  • Martín-Fontecha Corrales, María Del Mar
  • López Rodríguez, María Luz
Angiogenesis is a requirement for the sustained growth and proliferation of solid tumors, and the development of new compounds that induce a sustained inhibition of the proangiogenic signaling generated by tumor hypoxia still remains as an important unmet need. In this work, we describe a new antiangiogenic compound (22) that inhibits proangiogenic signaling under hypoxic conditions in breast cancer cells. Compound 22 blocks the MAPK pathway, impairs cellular migration under hypoxic conditions, and regulates a set of genes related to angiogenesis. These responses are mediated by HIF-1α, since the effects of compound 22 mostly disappear when its expression is knocked-down. Furthermore, administration of compound 22 in a xenograft model of breast cancer produced tumor growth reductions ranging from 46 to 55% in 38% of the treated animals without causing any toxic side effects. Importantly, in the responding tumors, a significant reduction in the number of blood vessels was observed, further supporting the mechanism of action of the compound. These findings provide a rationale for the development of new antiangiogenic compounds that could eventually lead to new drugs suitable for the treatment of some types of tumors either alone or in combination with other agents.
Docta Complutense
Publication Artículo científico (JournalArticle)

Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action

  • Artola, Marta
  • Ruiz Ávila, Laura
  • Vergonos, Albert
  • Huecas, Sonia
  • Araujo Bazán, Lidia
  • Martín-Fontecha Corrales, María Del Mar
  • Vázquez Villa, María Del Henar
  • Turrado, Carlos
  • Ramírez Aportela, Erney
  • Hoegl, Annabelle
  • Nodwell, Matthew
  • Barasoain, Isabel
  • Chacón, Pablo
  • Sieber, Stephan A.
  • Andreu, Jose M.
  • López Rodríguez, María Luz
Essential cell division protein FtsZ is considered an attractive target in the search for antibacterials with novel mechanisms of action to overcome the resistance problem. FtsZ undergoes GTP-dependent assembly at midcell to form the Z-ring, a dynamic structure that evolves until final constriction of the cell. Therefore, molecules able to inhibit its activity will eventually disrupt bacterial viability. In this work, we report a new series of small molecules able to replace GTP and to specifically inhibit FtsZ, blocking the bacterial division process. These new synthesized inhibitors interact with the GTP-binding site of FtsZ (Kd = 0.4–0.8 μM), display antibacterial activity against Gram-positive pathogenic bacteria, and show selectivity against tubulin. Biphenyl derivative 28 stands out as a potent FtsZ inhibitor (Kd = 0.5 μM) with high antibacterial activity [MIC (MRSA) = 7 μM]. In-depth analysis of the mechanism of action of compounds 22, 28, 33, and 36 has revealed that they act as effective inhibitors of correct FtsZ assembly, blocking bacterial division and thus leading to filamentous undivided cells. These findings provide a compelling rationale for the development of compounds targeting the GTP-binding site as antibacterial agents and open the door to antibiotics with novel mechanisms of action.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GPCRtm, An amino acid substitution matrix for the transmembrane region of class A G Protein-Coupled Receptors

  • Rios Azuara, Santiago
  • Fernandez, Marta F.
  • Caltabiano, Gianluigi|||0000-0002-2929-7069
  • Campillo Grau, María Mercedes|||0000-0002-6315-0212
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Gonzalez, Angel|||0000-0002-2284-8307
Protein sequence alignments and database search methods use standard scoring matrices calculated from amino acid substitution frequencies in general sets of proteins. These general-purpose matrices are not optimal to align accurately sequences with marked compositional biases, such as hydrophobic transmembrane regions found in membrane proteins. In this work, an amino acid substitution matrix (GPCRtm) is calculated for the membrane spanning segments of the G protein-coupled receptor (GPCR) rhodopsin family; one of the largest transmembrane protein family in humans with great importance in health and disease. The GPCRtm matrix reveals the amino acid compositional bias distinctive of the GPCR rhodopsin family and differs from other standard substitution matrices. These membrane receptors, as expected, are characterized by a high content of hydrophobic residues with regard to globular proteins. On the other hand, the presence of polar and charged residues is higher than in average membrane proteins, displaying high frequencies of replacement within themselves. Analysis of amino acid frequencies and values obtained from the GPCRtm matrix reveals patterns of residue replacements different from other standard substitution matrices. GPCRs prioritize the reactivity properties of the amino acids over their bulkiness in the transmembrane regions. A distinctive role is that charged and polar residues seem to evolve at different rates than other amino acids. This observation is related to the role of the transmembrane bundle in the binding of ligands, that in many cases involve electrostatic and hydrogen bond interactions. This new matrix can be useful in database search and for the construction of more accurate sequence alignments of GPCRs. The online version of this article (doi:10.1186/s12859-015-0639-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with G and G

  • Navarro Brugal, Gemma|||0000-0003-4654-0873
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Zelman-Femiak, Monika
  • Brugarolas, Marc
  • Moreno, Estefania
  • Aguinaga Andrés, David|||0000-0003-2506-7204
  • Pérez-Benito, Laura|||0000-0001-9607-9048
  • Cortés, Antoni
  • Casadó, Vicent|||0000-0002-1764-3825
  • Mallol, Josefa
  • Canela, Enric I.|||0000-0003-4992-7440
  • Lluís, Carme
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • García-Sáez, Ana J.
  • McCormick, Peter J.
  • Franco, Rafael|||0000-0003-2549-4919
G-protein-coupled receptors (GPCRs), in the form of monomers or homodimers that bind heterotrimeric G proteins, are fundamental in the transfer of extracellular stimuli to intracellular signaling pathways. Different GPCRs may also interact to form heteromers that are novel signaling units. Despite the exponential growth in the number of solved GPCR crystal structures, the structural properties of heteromers remain unknown. We used single-particle tracking experiments in cells expressing functional adenosine A-A receptors fused to fluorescent proteins to show the loss of Brownian movement of the A receptor in the presence of the A receptor, and a preponderance of cell surface 2:2 receptor heteromers (dimer of dimers). Using computer modeling, aided by bioluminescence resonance energy transfer assays to monitor receptor homomerization and heteromerization and G-protein coupling, we predict the interacting interfaces and propose a quaternary structure of the GPCR tetramer in complex with two G proteins. The combination of results points to a molecular architecture formed by a rhombus-shaped heterotetramer, which is bound to two different interacting heterotrimeric G proteins (G and G). These novel results constitute an important advance in understanding the molecular intricacies involved in GPCR function. The online version of this article (doi:10.1186/s12915-016-0247-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor

  • Stanley, Nathaniel
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Fabritiis, Gianni De
The binding process through the membrane bilayer of lipid-like ligands to a protein target is an important but poorly explored recognition process at the atomic level. In this work we succeeded in resolving the binding of the lipid inhibitor ML056 to the sphingosine-1-phosphate receptor 1 (S1PR) using unbiased molecular dynamics simulations with an aggregate sampling of over 800 μs. The binding pathway is a multi-stage process consisting of the ligand diffusing in the bilayer leaflet to contact a "membrane vestibule" at the top of TM 7, subsequently moving from this lipid-facing vestibule to the orthosteric binding cavity through a channel formed by TMs 1 and 7 and the N-terminal of the receptor. Unfolding of the N-terminal alpha-helix increases the volume of the channel upon ligand entry, helping to reach the crystallographic pose that also corresponds to the predicted favorable pose. The relaxation timescales of the binding process show that the binding of the ligand to the "membrane vestibule" is the rate-limiting step in the multi microseconds timescale. We comment on the significance and parallels of the binding process in the context of other binding studies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

TMalphaDB and TMbetaDB, web servers to study the structural role of sequence motifs in α-helix and β-barrel domains of membrane proteins

  • Perea, Marc
  • Lugtenburg, Ivar
  • Mayol, Eduardo|||0000-0003-3120-8667
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Deupi, Xavier|||0000-0003-4572-9316
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Olivella, Mireia|||0000-0002-6035-3399
Membrane proteins represent over 25 % of human protein genes and account for more than 60 % of drug targets due to their accessibility from the extracellular environment. The increasing number of available crystal structures of these proteins in the Protein Data Bank permits an initial estimation of their structural properties. We have developed two web servers-TMalphaDB for α-helix bundles and TMbetaDB for β-barrels-to analyse the growing repertoire of available crystal structures of membrane proteins. TMalphaDB and TMbetaDB permit to search for these specific sequence motifs in a non-redundant structure database of transmembrane segments and quantify structural parameters such as ϕ and ψ backbone dihedral angles, χ side chain torsion angle, unit bend and unit twist. The structural information offered by TMalphaDB and TMbetaDB permits to quantify structural distortions induced by specific sequence motifs, and to elucidate their role in the 3D structure. This specific structural information has direct implications in homology modeling of the growing sequences of membrane proteins lacking experimental structure. TMalphaDB and TMbetaDB are freely available at http://lmc.uab.cat/TMalphaDB and http://lmc.uab.cat/TMbetaDB.